A Minimally Invasive Surgery for Axillary Osmidrosis: Combined Liposuction With Subcutaneous Pruning

Sweat Gland Diseases Clinical Trial

Official title:

A Refined Minimally Invasive Procedure for Radical Treatment of Axillary Osmidrosis: Combined Tumescent Liposuction With Subcutaneous Pruning Through a Small Incision

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT01539460
• Other study ID #: TDH0369
• Status: Enrolling by invitation
• Phase: N/A
• First received: February 21, 2012
• Last updated: May 11, 2017
• Start date: February 2012
• Est. completion date: December 2017

Study information

• Verified date: May 2017
• Source: Tang-Du Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patients with axillary osmidrosis are treated with minimally invasive procedure combined tumescent liposuction with Subcutaneous Pruning. Effectiveness of this modified method in reducing odor is to be determined.

Description:

Patients with excessive malodor are recruited. They are surgically treated with minimally invasive procedure combined tumescent liposuction with Subcutaneous Pruning and followed up for 6-24 months to evaluate effectiveness sand side effect.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 30
• Est. completion date: December 2017
• Est. primary completion date: November 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• 18 years or older

• unpleasant odor from the axillae

• Willing and able to appear for all scheduled, post-operative visits

Exclusion Criteria:

• under the age of 18

• have undergone a prior surgical intervention

• inappropriate candidates for surgery due to medical or mental health reasons

• elect not to participate in the study

Related Conditions & MeSH terms

• Sweat Gland Diseases

Intervention

Procedure:
• minimally invasive surgery
Subcutaneous fat and apocrine sweat glands were removed by suction under tumescent anesthesia,and the remaining tissue and glands, tightly attached to the epidermis-dermis interface, were completely removed with scissors through the initial small incision.

Locations

Country	Name	City	State
China	Yuejun Li	Xi'an	Shaanxi

Sponsors (1)

Lead Sponsor	Collaborator
Tang-Du Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To assess the effectiveness of the refined minimally invasive procedure for radical treatment of axillary osmidrosis using patient self-report assessments	the satisfaction of patients	up to 24 months